These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6849633)

  • 1. Partial analysis and purification of polymorphonuclear neutrophil chemotactic inhibitors in serum from anergic patients.
    Christou NV; Meakins JL
    Arch Surg; 1983 Feb; 118(2):156-60. PubMed ID: 6849633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil function in surgical patients: in vitro correlation of abnormal neutrophil chemotaxis by Levamisole.
    Christou NV; Meakins JL
    Surgery; 1979 May; 85(5):543-8. PubMed ID: 432816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-directed inhibition of polymorphonuclear leukocyte chemotaxis in a patient with mucocutaneous candidiasis.
    Cates KL; Grady PG; Shapira E; Davis AT
    J Allergy Clin Immunol; 1980 Jun; 65(6):430-5. PubMed ID: 6989878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro polymorphonuclear neutrophil function in surgical patients does not correlate with anergy but with "activating" processes such as sepsis or trauma.
    Christou NV; Tellado JM
    Surgery; 1989 Oct; 106(4):718-22; discussion 722-4. PubMed ID: 2799647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytic and bactericidal functions of polymorphonuclear neutrophils from anergic surgical patients.
    Christou NV; Meakins JL
    Can J Surg; 1982 Jul; 25(4):444-8. PubMed ID: 7093842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of chemotactic factor inactivator in alcoholic liver disease.
    Robbins RA; Zetterman RK; Kendall TJ; Gossman GL; Monsour HP; Rennard SI
    Hepatology; 1987; 7(5):872-7. PubMed ID: 3653852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of glycogen-induced guinea pig polymorphonuclear leukocytes to detect inhibitors of chemotaxis found in human serum.
    Judd RC; Rudbach JA
    Diagn Immunol; 1985; 3(1):1-6. PubMed ID: 3995877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chemotactic factor inactivation in neutrophil chemotaxis.
    Tannous R; Cavender-Zylich N; Ginsberg BH
    J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
    Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
    J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
    Rhodes JM; Potter BJ; Brown DJ; Jewell DP
    Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective serum chemotactic capacity in rheumatoid arthritis.
    Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
    Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critically ill anergic patients demonstrate polymorphonuclear neutrophil activation in the intravascular compartment with decreased cell delivery to inflammatory focci.
    Tellado JM; Christou NV
    J Leukoc Biol; 1991 Dec; 50(6):547-53. PubMed ID: 1658171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of leukocyte chemotaxis by human IgA myeloma components.
    Van Epps DE; Williams RC
    J Exp Med; 1976 Nov; 144(5):1227-42. PubMed ID: 825608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil function in anergic surgical patients: neutrophil adherence and chemotaxis.
    Christou NV; Meakins JL
    Ann Surg; 1979 Nov; 190(5):557-64. PubMed ID: 507967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neutrophil granulocyte chemotaxis and psoriasis].
    Christophers E; Schröder JM
    Hautarzt; 1981 Nov; 32(11):558-63. PubMed ID: 6458581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by elastase inhibitors of the formyl Met Leu Phe-induced chemotaxis of rat polymorphonuclear leukocytes.
    Hornebeck W; Soleilhac JM; Tixier JM; Moczar E; Robert L
    Cell Biochem Funct; 1987 Apr; 5(2):113-22. PubMed ID: 3495371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral components of monocyte and neutrophil chemotaxis in cord blood.
    Pahwa SG; Pahwa R; Grimes E; Smithwick E
    Pediatr Res; 1977 May; 11(5):677-80. PubMed ID: 870874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.